GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immunocore Holdings PLC (NAS:IMCR) » Definitions » Inventories, Other

IMCR (Immunocore Holdings) Inventories, Other : $5.4 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Immunocore Holdings Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Immunocore Holdings's other inventories for the quarter that ended in Dec. 2024 was $5.4 Mil.

Immunocore Holdings's quarterly other inventories increased from Jun. 2024 ($3.5 Mil) to Sep. 2024 ($4.5 Mil) and increased from Sep. 2024 ($4.5 Mil) to Dec. 2024 ($5.4 Mil).

Immunocore Holdings's annual other inventories increased from Dec. 2022 ($0.7 Mil) to Dec. 2023 ($4.5 Mil) and increased from Dec. 2023 ($4.5 Mil) to Dec. 2024 ($5.4 Mil).


Immunocore Holdings Inventories, Other Historical Data

The historical data trend for Immunocore Holdings's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immunocore Holdings Inventories, Other Chart

Immunocore Holdings Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Other
Get a 7-Day Free Trial - - 0.69 4.50 5.45

Immunocore Holdings Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.50 4.17 3.46 4.52 5.45

Immunocore Holdings Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Immunocore Holdings Business Description

Traded in Other Exchanges
N/A
Address
92 Park Drive, Milton Park, Abingdon, Oxfordshire, GBR, OX14 4RY
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.